EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Randomisierte kontrollierte StudieOpen Access

Microbubble-based Radiosensitization of Hepatocellular Carcinoma: Evaluation of Safety and Efficacy in a Phase II Randomized Trial

Corinne E Wessner iD, Flemming Forsberg iD, Andrej Lyshchik iD, Patrick O'Kane iD, Kristen Bradigan iD, Ji-Bin Liu iD, Lauren J Delaney iD, Kevin Anton iD, Stephen R Topper iD, Jesse Civan iD, Warren Maley iD, Scott W Keith iD und 2 weitere

Radiology · 01.09.2025 · 316 (3)

DOI: 10.1148/radiol.250083 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift Radiology, erschienen am 01.09.2025. Verfasst von Corinne E Wessner und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Thomas Jefferson University, 132 S 10th St, Main Bldg, 7th Fl, Philadelphia, PA 19107. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Microbubbles, Yttrium Radioisotopes. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Compared with treatment with only 90 Y–transarterial radioembolization (TARE), adding microbubble-based radiosensitization via ultrasound-triggered microbubble destruction to 90 Y-TARE had similar safety, provided improved treatment response, and prolonged survival in participants with hepatocellular carcinoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsMicrobubblesYttrium RadioisotopesRadiation-Sensitizing AgentsEmbolization, TherapeuticHumansMaleFemaleMiddle AgedAgedProspective StudiesTreatment OutcomeContrast Media

Substanzen

Yttrium RadioisotopesRadiation-Sensitizing AgentsContrast Media

Autor:innen und Institutionen

  • Department of Radiology, Thomas Jefferson University, 132 S 10th St, Main Bldg, 7th Fl, Philadelphia, PA 19107.
  • School of Biomedical Engineering, Science, and Health Systems, Drexel University, Philadelphia, Pa.
  • Division of Gastroenterology & Hepatology, Department of Medicine, Thomas Jefferson University, Philadelphia, Pa.
  • Department of Surgery, Thomas Jefferson University, Philadelphia, Pa.
  • Division of Biostatistics and Bioinformatics, Thomas Jefferson University, Philadelphia, Pa.

ORCID-Profile: Corinne E Wessner, Flemming Forsberg, Andrej Lyshchik, Patrick O'Kane, Kristen Bradigan, Ji-Bin Liu, Lauren J Delaney, Kevin Anton, Stephen R Topper, Jesse Civan, Warren Maley, Scott W Keith, Colette M Shaw, John R Eisenbrey

Förderung

  • NCI NIH HHS

Zitieren

APA

Wessner, C. E., Forsberg, F., Lyshchik, A., O'Kane, P., Bradigan, K., Liu, J. B., Delaney, L. J., Anton, K., Topper, S. R., Civan, J., Maley, W., Keith, S. W., Shaw, C. M., & Eisenbrey, J. R. (2025). Microbubble-based Radiosensitization of Hepatocellular Carcinoma: Evaluation of Safety and Efficacy in a Phase II Randomized Trial. Radiology, 316(3). https://doi.org/10.1148/radiol.250083

Vancouver

Wessner CE, Forsberg F, Lyshchik A, O'Kane P, Bradigan K, Liu JB, et al. Microbubble-based Radiosensitization of Hepatocellular Carcinoma: Evaluation of Safety and Efficacy in a Phase II Randomized Trial. Radiology. 2025;316(3). doi:10.1148/radiol.250083

BibTeX
@article{Wessner2025,
  author = {Wessner, Corinne E and Forsberg, Flemming and Lyshchik, Andrej and O'Kane, Patrick and Bradigan, Kristen and Liu, Ji-Bin and Delaney, Lauren J and Anton, Kevin and Topper, Stephen R and Civan, Jesse and Maley, Warren and Keith, Scott W and Shaw, Colette M and Eisenbrey, John R},
  title = {Microbubble-based Radiosensitization of Hepatocellular Carcinoma: Evaluation of Safety and Efficacy in a Phase II Randomized Trial},
  journal = {Radiology},
  year = {2025},
  volume = {316},
  number = {3},
  doi = {10.1148/radiol.250083}
}
Kostenlos starten →